Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia

被引:21
作者
Carter, A [1 ]
Lin, K
Sherrington, PD
Atherton, M
Pearson, K
Douglas, A
Burford, A
Brito-Babapulle, V
Matutes, E
Catovsky, D
Pettitt, AR
机构
[1] Royal Liverpool Univ Hosp, Dept Haematol, Liverpool, Merseyside, England
[2] Liverpool Womens Hosp, Cheshire & Merseyside Genet Labs, Liverpool, Merseyside, England
[3] Inst Canc Res, Sect Haematooncol, Sutton, Surrey, England
关键词
D O I
10.1038/sj.leu.2404120
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:737 / 740
页数:5
相关论文
共 8 条
[1]   Detection of p53 dysfunction by flow cytometry in chronic lymphocytic leukaemia [J].
Carter, A ;
Lin, K ;
Sherrington, PD ;
Pettitt, AR .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (04) :425-428
[2]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[3]   High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment [J].
Lin, K ;
Manocha, S ;
Harris, RJ ;
Matrai, Z ;
Sherrington, PD ;
Pettitt, AR .
BLOOD, 2003, 102 (03) :1145-1146
[4]   Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukemia [J].
Lin, K ;
Sherrington, PD ;
Dennis, M ;
Matrai, Z ;
Cawley, JC ;
Pettitt, AR .
BLOOD, 2002, 100 (04) :1404-1409
[5]   p53 dysfunction in B-cell chronic lymphocytic leukemia:: inactivation of ATM as an alternative to TP53 mutation [J].
Pettitt, AR ;
Sherrington, PD ;
Stewart, G ;
Cawley, JC ;
Taylor, AMR ;
Stankovic, T .
BLOOD, 2001, 98 (03) :814-822
[6]   Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia [J].
Schaffner, C ;
Stilgenbauer, S ;
Rappold, GA ;
Döhner, H ;
Lichter, P .
BLOOD, 1999, 94 (02) :748-753
[7]   Genetics of chronic lymphocytic leukemia:: genomic aberrations and VH gene mutation status in pathogenesis and clinical course [J].
Stilgenbauer, S ;
Bullinger, L ;
Lichter, P ;
Döhner, H .
LEUKEMIA, 2002, 16 (06) :993-1007
[8]   Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia [J].
Thornton, PD ;
Gruszka-Westwood, AM ;
Hamoudi, RA ;
Atkinson, S ;
Kaczmarek, P ;
Morilla, RM ;
Hilditch, BL ;
A'Hern, R ;
Matutes, E ;
Catovsky, D .
HEMATOLOGY JOURNAL, 2004, 5 (01) :47-54